戻る Agenda
Artificial Intelligence: Real Applications and Regulatory Perspectives
Session Chair(s)
Jeremy Jokinen, PhD, MS
Vice President and Head Global Patient Safety
Argenx, United States
Artificial Intelligence (AI) remains a commonly used phrase with few examples of use within the pharmaceutical industry. In this session, speakers will share their experience with artificial intelligence applications across the healthcare industry. Speakers will discuss real-world applications of artificial intelligence and near-term opportunities currently being pursued by pharmaceutical and technology companies and healthcare systems. Additionally, this session will cover the perspective of regulators to this rapidly changing field. Speakers will share their perspectives regarding the future of these technologies to influence patient safety and healthcare broadly. Join the Clinical Safety & Pharmacovigilance Community for a follow up round table discussion (session #330.2 RT L) on Wednesday, June 30, 12:00PM - 1:00PM EDT.
Learning Objective : Describe current applications of AI within pharmaceutical, technology, and healthcare settings; Discuss evolving regulation and regulatory perspective; Identify the barriers to implementation of AI in healthcare; Assess the promise and pitfalls of these advanced technologies.
Speaker(s)
Developing a Deep Learning MedDRA Encoder (MedDRA-DeepCoder) for Patient Narratives
Tom Sabo, MS
SAS Institute Inc., United States
Principal Solutions Architect
Deep Learning at the FDA
Qais Hatim, PhD
FDA, United States
Data Scientist, OTS, CDER
Tailoring FDA's Regulatory Framework to Encourage Responsible Innovation in Artificial Intelligence and Machine Learning
Bakul Patel, MBA, MS
Google, United States
Sr. Director, Global Digital Health Strategy and Regulatory
Image Fingerprinting as a Means for Individual Case Safety Report Classification: A Convolutional Neural Network
Sameen Desai, MBA, MS
Bristol-Myers Squibb Company, United States
Executive Director, IT Worldwide Patient Safety
Human Factors and Responsible Use of Artificial Intelligence
Raj Ratwani, PhD
MedStar Health Research Institute, United States
Vice President of Scientific Affairs